/
„Mega“ trends & challenges in
Oncology
•
Aging population / increased comorbidities
•
Precision medicine / cancer as a chronic
disease
•
Tighter financial resources
•
Competition from minimal invasive Tx
ESTRO SBRT COURSE 2016 - Matthias Guckenberger
13